Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay

Schott, Sarah; Wallwiener, Markus; Kootz, Beate; Seeger, Harald; Fehm, Tanja; Neubauer, Hans

dc.contributor.author	Kootz, Beate	de_DE
dc.contributor.author	Seeger, Harald	de_DE
dc.contributor.author	Fehm, Tanja	de_DE
dc.contributor.author	Neubauer, Hans	de_DE
dc.date.accessioned	2014-03-24T14:30:33Z
dc.date.available	2014-03-24T14:30:33Z
dc.date.issued	2012	de_DE
dc.identifier.issn	0167-6997	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/50393
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s10637-011-9688-3	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01687	de_DE
utue.publikation.seiten	1750-1755	de_DE
utue.personen.roh	Schott, Sarah	de_DE
utue.personen.roh	Wallwiener, Markus	de_DE
utue.personen.roh	Kootz, Beate	de_DE
utue.personen.roh	Seeger, Harald	de_DE
utue.personen.roh	Fehm, Tanja	de_DE
utue.personen.roh	Neubauer, Hans	de_DE
dcterms.isPartOf.ZSTitelID	Investigational New Drugs	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	30	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE